Insider Trading History of Behbahani Ali


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Behbahani Ali since year 2005. The trader's CIK number is 1613867. At the time of the last reporting, Behbahani Ali was the Director of Black Diamond Therapeutics, Inc. . (stock ticker symbol BDTX). See this page for all insider trading activities at Black Diamond Therapeutics, Inc. .

Note that in the past Behbahani Ali also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Behbahani Ali since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-02-03 BDTX Black Diamond Therapeutics, Inc. Buy 800,000 19.00 15,200,000
2020-01-24 ADAP Adaptimmune Therapeutics Plc Buy 7,500,000 .67 5,002,500
2019-07-22 MIRM Mirum Pharmaceuticals, Inc. Buy 450,000 15.00 6,750,000
2019-06-24 GNCA Genocea Biosciences, Inc. Buy 2,857,142 3.50 9,999,997
2019-05-09 TRVI Trevi Therapeutics, Inc. Buy 2,500,000 10.00 25,000,000
2019-05-07 RGLS Regulus Therapeutics Inc. Buy 1,136,704 1.08 1,227,640
2019-02-14 GNCA Genocea Biosciences, Inc. Buy 9,948,269 .47 4,685,634
2018-09-07 ADAP Adaptimmune Therapeutics Plc Buy 12,000,000 1.67 20,004,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Behbahani Ali (Director of Black Diamond Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month